American giant buying South African-owned company for R14 billion

BusinessTech

Life Healthcare is selling Life Molecular Imaging (LMI) to Lantheus Radiopharmaceuticals UK Limited, a subsidiary of Lantheus Holdings Inc. The deal involves an upfront payment of USD350 million, with a potential additional payment of USD400 million linked to future sales milestones. LMI focuses on developing molecular imaging agents for PET-CT diagnostics and operates in the EU, UK, and USA.

Read More from source